Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial

Fibroadenoma (FA) is the most common benign solid breast mass in women, with no definite method of management. Because fibroadenoma is dependent on female sex hormones and comprises hypertrophic changes at cel...

Source: BMC Endocrine Disorders - August 20, 2021 Category: Endocrinology Authors: Sadaf Alipour, Mahboubeh Abedi, Azin Saberi, Arezoo Maleki-Hajiagha, Firoozeh Faiz, Saeed Shahsavari and Bita Eslami Tags: Research Source Type: research